Metabolic reprogramming-a breakthrough point in overcoming resistance to BRAF mutant melanoma targeted therapy (Review). [PDF]
Zhao X, Chen F, Li H.
europepmc +1 more source
ORY1001 enhances anti-tumor immunity via CXCL10-mediated macrophage modulation in EBV-positive DLBCL. [PDF]
Kim JH, Cho HJ, Yoon SE, Kim WS.
europepmc +1 more source
Regulation of androgen receptor expression by enhancer elements in prostate cancer. [PDF]
Khadka S, Jeon HY, Hussain A, Qi J.
europepmc +1 more source
LSD1 inhibition sensitizes anti-PD1 blockade immunotherapy by inhibiting the long-range attack of tumor-derived extracellular vesicles. [PDF]
Zhao Y +7 more
europepmc +1 more source
Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer. [PDF]
Zhu Y, Liu K, Zhu H.
europepmc +1 more source
Lysine-specific histone demethylase complex restricts Epstein-Barr virus lytic reactivation. [PDF]
Liao Y +9 more
europepmc +1 more source
CoREST complex inhibition alters RNA splicing to promote neoantigen expression and enhance tumor immunity. [PDF]
Fisher RJ +23 more
europepmc +1 more source
Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential. [PDF]
Abdelsayed M, Boulaamane Y.
europepmc +1 more source
Lysine-specific histone demethylase 1 (LSD1) [PDF]
openaire +2 more sources
Molecular mechanisms involved in lysine-specific demethylase 1 mediated oncogenic stress [PDF]
Dalvi, Priya Shivaji
core

